Karl Stubelis

Karl Stubelis is an accomplished finance professional with extensive experience in leadership roles within the healthcare and technology sectors. Currently serving as the Chief Financial Officer at Verb Biotics, Stubelis has previously held senior financial positions, including Vice President of Finance at Exact Sciences and VP of Finance at Thrive Earlier Detection, a company acquired by Exact Sciences. Stubelis also has a strong background as Chief Financial Officer for Ovia Health and Data Intensity. Academic credentials include a Bachelor of Science in Accounting and Finance from the University of Vermont and an MBA in Business Administration from Suffolk University.